UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors

Current oncology (Toronto), 2023-05, Vol.30 (6), p.5279-5298

2023

Volltextzugriff (PDF)

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001532

2020

Volltextzugriff (PDF)

Neurolymphomatosis: A case series of clinical manifestations, treatments, and outcomes

Journal of the neurological sciences, 2014-08, Vol.343 (1), p.144-148

2014

Volltextzugriff (PDF)

Myelopathy following intrathecal chemotherapy in adults: a single institution experience

Journal of neuro-oncology, 2015-04, Vol.122 (2), p.391-398

2015

Volltextzugriff (PDF)

Ependymomas arising outside of the central nervous system: A case series and literature review

Journal of clinical neuroscience, 2018-01, Vol.47, p.202-207

2018

Volltextzugriff (PDF)

Dorsal column myelopathy after intrathecal chemotherapy for leukemia

American journal of hematology, 2017-02, Vol.92 (2), p.155-160

2017

Volltextzugriff (PDF)

Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma

Neuro-oncology (Charlottesville, Va.), 2014-04, Vol.16 (4), p.589-593

2014

Volltextzugriff (PDF)

Neuromuscular Weakness Syndromes from Immune Checkpoint Inhibitors: A Case Series and Literature Review

Journal of Immunotherapy and Precision Oncology, 2019-08, Vol.2 (3), p.93-100

2019

Volltextzugriff (PDF)

Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab

Neurology : neuroimmunology & neuroinflammation, 2014-12, Vol.1 (4), p.e41-e41

2014

Volltextzugriff (PDF)

BIOM-47. CLINICAL AND MOLECULAR FEATURES OF PATIENTS WITH LI-FRAUMENI SYNDROME AND GLIOMA: AN MD ANDERSON CANCER CENTER EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v15-v15

2023

Volltextzugriff (PDF)

Electrographic patterns in patients with posterior reversible encephalopathy syndrome and seizures

Journal of the neurological sciences, 2017-04, Vol.375, p.294-298

2017

Volltextzugriff (PDF)

Long-term Survival in a WHO Grade 4 IDH-mutant Astrocytoma Using a Farnesyltransferase Inhibitor in Combination with Temozolomide (P4-5.006)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Single center experience of IDH inhibitors in high-grade gliomas

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e14036-e14036

2024

Volltextzugriff (PDF)

Patient With 2 Hematologic Malignancies Presenting as Neurolymphomatosis

Journal of clinical neuromuscular disease, 2018-03, Vol.19 (3), p.124-130

2018

Volltextzugriff (PDF)

CTNI-46. UPFRONT VERSUS DEFERRED TREATMENT IN LOWER GRADE IDH-MUTANT GLIOMAS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v85-v85

2023

Volltextzugriff (PDF)

CTNI-54. LONG-TERM USE OF EVEROLIMUS PLUS OCTREOTIDE FOR RECURRENT INTRACRANIAL OR SPINAL MENINGIOMA: A SINGLE INSTITUTION EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Suppl 2), p.ii55-ii55

2020

Volltextzugriff (PDF)

Atypical isolated nuclear oculomotor nerve syndrome: A diagnostic challenge (P1.031)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

The path forward for anti-programmed cell death-1 therapy in gliomas

Current opinion in neurology, 2019-12, Vol.32 (6), p.864-871

2019

Volltextzugriff (PDF)

Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2181-2190

2023

Volltextzugriff (PDF)

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature medicine, 2023-01, Vol.29 (1), p.115-126

2023

Volltextzugriff (PDF)

DDDR-34. RECURRENT RELA FUSION-POSITIVE EPENDYMOMA TREATED WITH VAL-083 UNDER EXPANDED ACCESS: A CASE REPORT

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii106-vii106

2022

Volltextzugriff (PDF)

DDDR-36. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii107-vii107

2022

Volltextzugriff (PDF)

CN-09 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME AND PRIMARY BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v47-v48

2014

Volltextzugriff (PDF)

Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy

Journal of neurosurgery, 2023-09, Vol.139 (3), p.1-809

2023

Volltextzugriff (PDF)

Analysis of tumor progression among patients with glioma after COVID-19 infection

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2041-2041

2023

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(130)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

Neurolymphomatosis: A case series of clinical manifestations, treatments, and outcomes

Myelopathy following intrathecal chemotherapy in adults: a single institution experience

Ependymomas arising outside of the central nervous system: A case series and literature review

Dorsal column myelopathy after intrathecal chemotherapy for leukemia

Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma

Neuromuscular Weakness Syndromes from Immune Checkpoint Inhibitors: A Case Series and Literature Review

Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab

BIOM-47. CLINICAL AND MOLECULAR FEATURES OF PATIENTS WITH LI-FRAUMENI SYNDROME AND GLIOMA: AN MD ANDERSON CANCER CENTER EXPERIENCE

Electrographic patterns in patients with posterior reversible encephalopathy syndrome and seizures

Long-term Survival in a WHO Grade 4 IDH-mutant Astrocytoma Using a Farnesyltransferase Inhibitor in Combination with Temozolomide (P4-5.006)

Single center experience of IDH inhibitors in high-grade gliomas

Patient With 2 Hematologic Malignancies Presenting as Neurolymphomatosis

CTNI-46. UPFRONT VERSUS DEFERRED TREATMENT IN LOWER GRADE IDH-MUTANT GLIOMAS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

CTNI-54. LONG-TERM USE OF EVEROLIMUS PLUS OCTREOTIDE FOR RECURRENT INTRACRANIAL OR SPINAL MENINGIOMA: A SINGLE INSTITUTION EXPERIENCE

Atypical isolated nuclear oculomotor nerve syndrome: A diagnostic challenge (P1.031)

The path forward for anti-programmed cell death-1 therapy in gliomas

Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

DDDR-34. RECURRENT RELA FUSION-POSITIVE EPENDYMOMA TREATED WITH VAL-083 UNDER EXPANDED ACCESS: A CASE REPORT

DDDR-36. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM

CN-09 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME AND PRIMARY BRAIN TUMORS

Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy

Analysis of tumor progression among patients with glioma after COVID-19 infection

Suchergebnisse filtern